We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$20.4B
AUM Growth
-$79M
Cap. Flow
-$151M
Cap. Flow %
-0.74%
Top 10 Hldgs %
31.15%
Holding
1,305
New
241
Increased
339
Reduced
426
Closed
291

Top Buys

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$166M
2
BNS icon
Scotiabank
BNS
+$139M
3
TD icon
Toronto Dominion Bank
TD
+$129M
4
CVE icon
Cenovus Energy
CVE
+$117M
5
PBA icon
Pembina Pipeline
PBA
+$89.3M

Top Sells

Rank Stock Value
1
CCJ icon
Cameco
CCJ
+$85.9M
2
NVDA icon
NVIDIA
NVDA
+$70.9M
3
CIXX
CI Financial Corp.
CIXX
+$70.7M
4
MSFT icon
Microsoft
MSFT
+$68.2M
5
GRP.U
Granite Real Estate Investment Trust
GRP.U
+$63.1M

Sector Composition

Rank Sector Weight
1 Financials 27.05%
2 Technology 13%
3 Energy 12.62%
4 Industrials 11.87%
5 Materials 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLT
1001
DELISTED
Applied Therapeutics
APLT
$53K ﹤0.01%
+25,015
New +$67K
DRRX
1002
DELISTED
DURECT Corp
DRRX
$53K ﹤0.01%
+7,873
New +$54.7K
TUSK icon
1003
Mammoth Energy Services
TUSK
$157M
$53K ﹤0.01%
+24,808
New +$45K
ATNX
1004
DELISTED
Athenex, Inc. Common Stock
ATNX
$52K ﹤0.01%
3,149
-1,016
-24% -$19.9K
CIH
1005
DELISTED
China Index Holdings Limited American Depository Shares
CIH
$42K ﹤0.01%
39,415
-175
-0.4% -$173
UBX
1006
DELISTED
Unity Biotechnology
UBX
$38K ﹤0.01%
3,392
-6,036
-64% -$67.7K
DTIL icon
1007
Precision BioSciences
DTIL
$202M
$36K ﹤0.01%
388
+13
+3% +$1.77K
FBIO icon
1008
Fortress Biotech
FBIO
$99M
$31K ﹤0.01%
1,516
+279
+23% +$7.64K
SLDB icon
1009
Solid Biosciences
SLDB
$991M
$25K ﹤0.01%
1,400
-7,952
-85% -$140K
LCTX icon
1010
Lineage Cell Therapeutics
LCTX
$268M
$18K ﹤0.01%
+12,000
New +$18.6K
LVO icon
1011
LiveOne
LVO
$59.7M
$13K ﹤0.01%
1,608
-7,874
-83% -$68.6K
LBTYA icon
1012
Liberty Global Class A
LBTYA
$3.58B
$4K ﹤0.01%
141
-2
-1% -$53
BATRK icon
1013
Atlanta Braves Holdings Series B
BATRK
$3.42B
$1K ﹤0.01%
33
– –
NWS icon
1014
News Corp Class B
NWS
$17.8B
$1K ﹤0.01%
38
– –
AAOI icon
1015
Applied Optoelectronics
AAOI
$11.3B
– –
-10,416
Closed -$54K
AAP icon
1016
Advance Auto Parts
AAP
$3.49B
– –
-9,587
Closed -$2.3M
ACGL icon
1017
Arch Capital
ACGL
$33.5B
– –
-75,478
Closed -$3.35M
ACIW icon
1018
ACI Worldwide
ACIW
$5.41B
– –
-27,267
Closed -$946K
ACR
1019
ACRES Commercial Realty
ACR
$101M
– –
-30,554
Closed -$381K
ADM icon
1020
Archer Daniels Midland
ADM
$38.7B
– –
-15,027
Closed -$1.02M
ALLY icon
1021
Ally Financial
ALLY
$13.6B
– –
-29,077
Closed -$1.38M
AMBA icon
1022
Ambarella
AMBA
$3.6B
– –
-2,862
Closed -$581K
AME icon
1023
Ametek
AME
$58.8B
– –
-34,855
Closed -$5.13M
AN icon
1024
AutoNation
AN
$6.89B
– –
-10,471
Closed -$1.22M
AOSL icon
1025
Alpha and Omega Semiconductor
AOSL
$890M
– –
-14,778
Closed -$895K
39 40
41
42 43

Similar funds

State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2022 Portfolio in Review

As of Q1 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,305 positions worth $20.4B, down 0.39% from $20.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2022 filing shows 241 new, 339 increased, 426 reduced and 291 closed positions. Its largest new stake was CVS Health: 264,540 shares worth $26.8M. The largest sale was Cameco, an estimated $85.9M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Technology and Energy.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2022 buy was CVS Health: 264,540 shares worth $26.8M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Enbridge in Q1 2022, an estimated $166M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2022 reduction was Cameco, cutting an estimated $85.9M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Kirkland Lake Gold Ltd Ordinary in Q1 2022, selling an estimated $21.5M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 31% of its $20.4B portfolio in Q1 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 241 new positions and closed 291 in Q1 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 0.39% quarter-over-quarter to $20.4B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2022, filed 12 May 2022.